Loomis Sayles & CO L P Lexicon Pharmaceuticals, Inc. Transaction History

Loomis Sayles & CO L P

  • $76.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018
SELL
$8.77 - $12.28 $8.65 Million - $12.1 Million
-986,386 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$12.17 - $16.3 $1.25 Million - $1.68 Million
103,037 Added 11.66%
986,386 $12.1 Million
Q2 2017

Aug 14, 2017
BUY
N/A
883,349
883,349 $14.5 Million

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email